ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR/ARHP Annual Meeting 2014

Abstract Number: 998

β2 Adrenoceptor Signal Is Augmented in B Cells in the Course of Arthritis to Increase IL-10

Georg Pongratz1, Clemens Wiest2, Madlen Melzer2 and Rainer Straub3, 1Internal Medicine I, University Hospital Regensburg, Regensburg, Germany, 2University Hospital Regensburg, Regensburg, Germany, 3Internal Medicine, University Hospital Regensburg, Regensburg, Germany

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR/ARHP Annual Meeting 2014

Keywords: Animal models, B cells, interleukins (IL), Neuroendocrine Immune (NEI), regulatory cells and rheumatoid arthritis

Session Information

Title: B cell Biology and Targets in Autoimmune Disease: Rheumatoid Arthritis and Related Diseases

Session Type: Abstract Submissions (ACR)

Background/Purpose

Splenic B cells from collagen-induced arthritis (CIA) mice react to a β2-adrenoceptor (AR) stimulus with increased IL-10 production and adoptive transfer of these cells decreases disease activity. However, B cells from unimmunized mice do not adequately increase IL-10. Therefore, we test the hypothesis that sensitivity to catecholamines changes during CIA. Furthermore, we wanted to test if human peripheral blood B cells from osteoarthritis (OA) and rheumatoid arthritis (RA) patients also increase IL-10 following a β2-adrenergic stimulus.

Methods

FACS to determine AR pathway related proteins (β2-adrenoceptor, G-protein coupled receptor kinase (GRK) 2, phophorylated and unphosphorylated mitogen activated protein kinase p38, and cAMP responsive element binding protein (CREB)) in B cells at different timepoints during CIA. Unstimulated splenic B cells and B cells stimulated with terbutalin, a β2-AR agonist, were used. Human B cells were isolated from peripheral blood of patients with OA or RA and stimulated under different conditions with and without terbutalin. IL-10 protein level was determined by ELISA after 5 days of culture.

Results

In the course of CIA the percentage of β2-AR+ B cells increased and stayed above baseline (ANOVA p<0.05). In contrast, the mean fluorescence intensity (MFI) as measure for the number of receptors per cell remained unchanged. MFI for GRK2 decreased and stayed low from day 6 p.i. (ANOVA p<0.0001). The relative increase in phosphorylation of p38 (ANOVA p<0.001) and CREB (ANOVA p<0.001) following a β2-AR stimulus was augmented starting at day 18 p.i. with a maximum response at day 55 p.i. in the late phase of CIA. In human B cells, similar mechanisms are in place, because β2-AR stimulation of RA, but not OA B cells increased IL-10. 

Conclusion

The current data show, that B cells become more sensitive to β2-AR stimuli in the course of CIA, possibly due to a decrease in GRK2 and increase in the percentage of β2-AR expressing splenic B cells. Increased catecholamine sensitivity might support B cell and IL-10 mediated anti-inflammatory mechanisms primarily in the late phase of CIA. A similar mechanism is observed in human peripheral B cells and might be used to improve treatment of autoimmune arthritis.


Disclosure:

G. Pongratz,
None;

C. Wiest,
None;

M. Melzer,
None;

R. Straub,
None.

ACR Meeting Abstracts - https://acrabstracts.org/abstract/%ce%b22-adrenoceptor-signal-is-augmented-in-b-cells-in-the-course-of-arthritis-to-increase-il-10/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology